- Approval Id
- 3bc8f114b9963d0e
- Drug Approval Philippines Name
- Synflorix
- Product Name
- Synflorix
- Registration Number
- BR-685
- Brand Name
- Synflorix
- Generic Name
- Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed)
- Dosage Form
- Suspension for Injection (IM)
- Dosage Strength
- Each 0.5 mL dose contains:
1 mcg of polysaccharide for serotypes 1 1,2, 5 1,2, 6B 1,2, 7F1.2, 9V 1,2, 14 1,2 and 23F 1,2 and 3 mcg of serotypes 4 1,2, 18C 1,3, and 19F 1,4
'Adsorbed on aluminium phosphate 500 mcg A 13+ 2Conjugate to protein D (derived from Non-Typeable Haemophilus influenzae) carrier protein eq. to 9-16 mcg
3Conjugate to tetanus toxoid carrier protein eq. to 5-10 mcg
4Conjugate to diphtheria toxoid carrier protein e.q. to 3-6 mcg
- Manufacturer
- GlaxoSmithKline Biologicals S.A.
- Importer
- GlaxoSmithKline Philippines, Inc.
- Distributor
- GlaxoSmithKline Philippines, Inc.
- Company Detail Path
- /organization/glaxosmithkline-biologicals-sa
- Issuance Date
- 25 July 2024
- Expiry Date
- 26 June 2029
- Pharmacologic Category
- Pneumococcal Vaccine
- Classification
- Prescription Drug (RX)
